086450 — DongKook Pharmaceutical Co Cashflow Statement
0.000.00%
- KR₩823bn
- KR₩862bn
- KR₩731bn
- 80
- 40
- 92
- 85
Annual cashflow statement for DongKook Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 59,050 | 57,880 | 52,916 | 54,757 | 48,871 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 19,888 | 32,912 | 16,641 | 18,491 | 23,612 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -23,061 | -46,786 | -42,251 | -51,515 | -51,774 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 69,483 | 59,108 | 44,654 | 40,909 | 41,793 |
Capital Expenditures | -25,185 | -41,394 | -51,421 | -51,230 | -39,350 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -30,653 | -55,546 | 7,891 | 38,822 | -13,041 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -55,838 | -96,940 | -43,530 | -12,408 | -52,391 |
Financing Cash Flow Items | -1,221 | -1,809 | -1,437 | 672 | -2,472 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4,916 | 22,959 | 29,733 | -39,792 | -2,298 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8,458 | -15,723 | 30,907 | -11,750 | -13,141 |